The Peripheral Nervous System Complications of HTLV-1 Myelopathy (HAM/TSP) Syndromes

 

 Buy Article Permissions and Reprints

ABSTRACT

Human T-cell lymphotropic virus type I (HTLV-1) is a human retrovirus and the etiologic agent for a progressive neurological disease called HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). With its primary site of involvement occurring at the thoracic spinal cord level, HAM/TSP is characterized by muscle weakness, hyperreflexia, lower extremity spasticity, and urinary disturbance. However, HAM/TSP has also been associated with other autoimmune disorders as well as widespread dysfunction within the nervous system that results in less frequent symptoms of cerebral, cerebellar, and cranial nerve involvement. Although masked by the more prominent myelopathy, involvement of the peripheral nervous system also occurs. Syndromes of anterior horn cell, peripheral nerve, and muscle dysfunction have been reported.

REFERENCES

• 1 Montgomery R D, Cruickshank E K, Robertson W B, McMenemey W H. Clinical and pathological observations on Jamaican neuropathy.  Brain. 1964;  87 425-462
  PubMedGoogle Scholar
• 2 Rodgers-Johnson P, Morgan O S, Mora C et al.. The role of HTLV-I in tropical spastic paraparesis in Jamaica.  Ann Neurol. 1988;  23(suppl) S121-S126
  CrossrefPubMedGoogle Scholar
• 3 Gessain A, Barin F, Vernant J C et al.. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis.  Lancet. 1985;  2 407-410
  PubMedGoogle Scholar
• 4 Osame M, Usuku K, Izumo S et al.. HTLV-1 associated myelopathy, a new clinical entity [letter].  Lancet. 1986;  1 1031-1032
  PubMedGoogle Scholar
• 5 Sugimura K, Takahashi A, Watanabe M, Mano K, Watanabe H. Demyelinating changes in sural nerve biopsy of patients with HTLV-I-associated myelopathy.  Neurology. 1990;  40 1263-1266
  PubMedGoogle Scholar
• 6 Román G C. The neuroepidemiology of tropical spastic paresis.  Ann Neurol. 1988;  23(suppl) S113-S120
  CrossrefPubMedGoogle Scholar
• 7 Uchiyama T. Human T cell leukemia virus type I (HTLV-I).  Annu Rev Immunol. 1997;  15 15-37
  CrossrefPubMedGoogle Scholar
• 8 Nakagawa M, Izumo S, Ijichi S et al.. HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings.  J Neurovirol. 1995;  1 50-61
  PubMedGoogle Scholar
• 9 Di Rocco A. HIV-associated myelopathy.  Current Treatment Options in Infectious Diseases. 2003;  5 457-465
  PubMedGoogle Scholar
• 10 Zaninovic V. Similarities between tropical spastic paraparesis (TSP) and neurolathyrism.  Lathyrus Lathyrism Newsletter. 2001;  2 11-14
  PubMedGoogle Scholar
• 11 Araújo A, Hall W W. Human T-lymphotropic virus type II and neurological disease.  Ann Neurol. 2004;  56 10-19
  CrossrefPubMedGoogle Scholar
• 12 Edlich R F, Arnette J A, Williams F M. Global epidemic of human T-cell lymphotropic virus type-1 (HTLV-1).  J Emerg Med. 2000;  18 109-119
  CrossrefPubMedGoogle Scholar
• 13 Simms I, Tosswill J HC, Noone A, Morgan D. Surveillance of HTLV infection in England and Wales: 1986-1992.  Commun Dis Rep CDR Rev. 1994;  4 R65-R69
  PubMedGoogle Scholar
• 14 Vrielink H, Reesink H W. HTLVI/II prevalence in different geographic locations.  Transfus Med Rev. 2004;  18 46-57
  CrossrefPubMedGoogle Scholar
• 15 Vernant J C, Maurs L, Gessain A et al.. Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type 1: a clinical and seroepidemiological study of 25 cases.  Ann Neurol. 1987;  21 123-130
  CrossrefPubMedGoogle Scholar
• 16 Araújo A de Q, Afonso C R, Schor D, Leite A C, de Andrada-Serpa M J. Clinical and demographic features of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Rio de Janeiro, Brazil.  Acta Neurol Scand. 1993;  88 59-62
  PubMedGoogle Scholar
• 17 Bhigjee A I, Kelbe C, Haribhal H C et al.. Myelopathy associated with human T cell lymphotropic virus type I (HTLV-I) in Natal, South Africa.  Brain. 1990;  113 1307-1320
  PubMedGoogle Scholar
• 18 Tylleskär T, Banea M, Bikangi N, Cooke R D, Poulter N H, Rosling H. Cassava cyanogens and konzo, an upper motoneuron disease found in Africa.  Lancet. 1992;  339 208-211
  CrossrefPubMedGoogle Scholar
• 19 Ludolph A C, Spencer P S. Toxic models of upper motor neuron disease.  J Neurol Sci. 1996;  139 53-59
  CrossrefPubMedGoogle Scholar
• 20 Tylleskar T, Banea M, Bikangi N, Cooke R D, Poulter N H, Rosling H. Cassava cyanogens and konzo, an upper motoneuron disease found in Africa.  Lancet. 1992;  339 208-211
  CrossrefPubMedGoogle Scholar
• 21 Getahun H, Mekonnen A, TekleHaimanot R, Lambein F. Epidemic of neurolathyrism in Ethiopia.  Lancet. 1999;  354 306-307
  CrossrefPubMedGoogle Scholar
• 22 Getahun H, Lambein F, Vanhoorne M, Van der Stuyft P. Pattern and associated factors of the neurolathyrism epidemic in Ethiopia.  Trop Med Int Health. 2002;  7 118-124
  PubMedGoogle Scholar
• 23 Shasi Vardhan K, Pratap Rudra M P, Rao S L. Inhibition of tyrosine aminotransferase by β-N-oxalyl-L-a‚β-diaminopropionic acid, the Lathyrus sativus neurotoxin.  J Neurochem. 1997;  68 2477-2484
  PubMedGoogle Scholar
• 24 Oluwole O SA, Onabolu A O, Link H, Rosling H. Persistence of tropical ataxic neuropathy in a Nigerian community.  J Neurol Neurosurg Psychiatry. 2000;  69 96-101
  CrossrefPubMedGoogle Scholar
• 25 Oluwole O SA, Onabolu A O, Cotgreave I A, Rosling H, Persson A, Link H. Incidence of endemic ataxic polyneuropathy and its relation to exposure to cyanide in a Nigerian community.  J Neurol Neurosurg Psychiatry. 2003;  74 1417-1422
  CrossrefPubMedGoogle Scholar
• 26 Oluwole O SA, Onabolu A O, Link H, Rosling H. Persistence of tropical ataxic neuropathy in a Nigerian community.  J Neurol Neurosurg Psychiatry. 2000;  69 96-101
  CrossrefPubMedGoogle Scholar
• 27 Kaplan J E, Osama M, Kubota H et al.. The risk of development of HTLV-1-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I.  J Acquir Immune Defic Syndr. 1990;  3 1096-1101
  PubMedGoogle Scholar
• 28 Nagai M, Usuku K, Matsumoto W et al.. Analysis of HTLV-1 proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-1 carriers: high proviral load strongly predisposes to HAM/TSP.  J Neurovirol. 1998;  4 586-593
  PubMedGoogle Scholar
• 29 Gout O, Baulac M, Gessain A et al.. Rapid development of myelopathy after HTLV-I infection acquired by transfusion during cardiac transplantation.  N Engl J Med. 1990;  322 383-388
  PubMedGoogle Scholar
• 30 Toro C, Rodé B, Poveda E, Soriano V. Rapid development of subacute myelopathy in three organ transplant recipients after transplantation of human T-cell lymphotropic virus type I from a single donor.  Transplantation. 2003;  75 102-104
  PubMedGoogle Scholar
• 31 Jacobson S. Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease.  J Infect Dis. 2002;  186(suppl 2) 187-192
  CrossrefPubMedGoogle Scholar
• 32 Imirizaldu J J, Esteban J C, Axpe I R et al.. Post-transplantation HTLV-1 myelopathy in three recipients from a single donor.  J Neurol Neurosurg Psychiatry. 2003;  74 1080-1084
  CrossrefPubMedGoogle Scholar
• 33 Izumo S, Goto I, Itoyama Y et al.. Interferon-alpha is effective in HTLV-I associated myelopathy: a multicenter, double-blind, controlled trial.  Neurology. 1996;  46 1016-1021
  CrossrefPubMedGoogle Scholar
• 34 Alamy A H, Menezes F B, Leite A C, Nascimento O M, Araujo A Q. Dysautonomia in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.  Ann Neurol. 2001;  50 681-685
  CrossrefPubMedGoogle Scholar
• 35 Silva M TT, Mattos P, Alfano A, Araújo A Q-C. Neuropsychological assessment in HTLV-1 infection: a comparative study among TSP/HAM, asymptomatic carriers, and healthy controls.  J Neurol Neurosurg Psychiatry. 2003;  74 1085-1089
  CrossrefPubMedGoogle Scholar
• 36 Nakagawa M, Nakahara K, Maruyama Y et al.. Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis.  J Neurovirol. 1996;  2 345-355
  CrossrefPubMedGoogle Scholar
• 37 Saito M, Nakagawa M, Kaseda S et al.. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-α therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.  J Infect Dis. 2004;  189 29-40
  PubMedGoogle Scholar
• 38 Silva M T, Araújo A. Spinal cord swelling in human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis.  Arch Neurol. 2004;  61 1134-1135
  CrossrefPubMedGoogle Scholar
• 39 Iwasaki Y. Human T cell leukemia virus type I infection and chronic myelopathy.  Brain Pathol. 1993;  3 1-10
  PubMedGoogle Scholar
• 40 Abe M, Umehara F, Kubota R, Moritoyo T, Izumo S, Osame M. Activation of macrophages/microglia with the calcium-binding proteins MRP14 and MRP8 is related to the lesional activities in the spinal cord of HTLV-I associated myelopathy.  J Neurol. 1999;  246 358-364
  PubMedGoogle Scholar
• 41 Retroviruses. In: Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA Medical Microbiology. 4th ed. St. Louis; Mosby 2002: 574-590
  Google Scholar
• 42 Derse D, Heidecker G. Virology: forced entry-or does HTLV-1 have the key? [comments].  Science. 2003;  299 1670-1671
  CrossrefPubMedGoogle Scholar
• 43 Hisada M, Stuver S O, Okayama A et al.. Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers.  J Infect Dis. 2004;  190 1605-1609
  CrossrefPubMedGoogle Scholar
• 44 Hisada M, Maloney E M, Sawada T et al.. Virus markers associated with vertical transmission of human T lymphotropic virus type 1 in Jamaica.  Clin Infect Dis. 2002;  34 1551-1557
  CrossrefPubMedGoogle Scholar
• 45 Bangham C RM. Human T-lymphotropic virus type 1 (HTLV-1): persistence and immune control.  Int J Hematol. 2003;  78 297-303
  PubMedGoogle Scholar
• 46 Barmak K, Harhaj E, Grant C, Alefantis T, Wigdahl B. Human T cell leukemia virus type I induced disease: pathways to cancer and neurodegeneration.  Virology. 2003;  308 1-12
  CrossrefPubMedGoogle Scholar
• 47 Brew B J. The peripheral nerve complications of human immunodeficiency virus (HIV) infection.  Muscle Nerve. 2003;  28 542-552
  CrossrefPubMedGoogle Scholar
• 48 Kiwaki T, Umehara F, Arimura Y et al.. The clinical and pathological features of peripheral neuropathy accompanied with HTLV-I associated myelopathy.  J Neurol Sci. 2003;  206 17-21
  CrossrefPubMedGoogle Scholar
• 49 Arimura K, Arimura Y, Moritoyo H et al.. How helpful is thoracic paraspinal EMG in HAM/TSP?.  Muscle Nerve. 1995;  18 248-250
  PubMedGoogle Scholar
• 50 Corbin D O, Mora C A, Garriques S, Rodgers-Johnson P, Gibbs C J. Anterior horn cell degeneration in polymyositis associated with human T lymphotropic virus type-1 in patients from Barbados.  Am J Trop Med Hyg. 1996;  54 625-628
  PubMedGoogle Scholar
• 51 Ross M A, Miller R G, Berchert L et al.. Toward earlier diagnosis of amyotrophic lateral sclerosis: revised criteria.  Neurology. 1998;  50 768-772
  PubMedGoogle Scholar
• 52 Matsuzaki T, Nakagawa M, Nagai M et al.. HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) with amyotrophic lateral sclerosis-like manifestations.  J Neurovirol. 2000;  6 544-548
  PubMedGoogle Scholar
• 53 Kuroda Y, Sugihara H. Autopsy report of HTLV-I-associated myelopathy presenting with ALS-like manifestations.  J Neurol Sci. 1991;  106 199-205
  CrossrefPubMedGoogle Scholar
• 54 Vernant J C, Buisson G, Bellance R, Francois M A, Madkaud O, Zavaro O. Pseudo-amyotrophic lateral sclerosis, peripheral neuropathy and chronic polyradiculoneuritis in patients with HTLV-I-associated paraplegias. In: Roman G, Vernant JC, Osame M HTLV-1 and the Nervous System. New York; Alan R. Liss, Inc. 1989: 361-365
  Google Scholar
• 55 Evans B K, Gore I, Harrell L E, Arnold T, Oh S J. HTLV-I-associated myelopathy and polymyositis in a US native.  Neurology. 1989;  39 1572-1575
  PubMedGoogle Scholar
• 56 Arimura K, Nakashima H, Matsumoto W et al.. HTLV-I-associated myelopathy (HAM) presenting with ALS-like features. In: Roman G, Vernant JC, Osame M HTLV-1 and the Nervous System. New York; Alan R. Liss, Inc. 1989: 367-370
  Google Scholar
• 57 Cruickshank J K, Rudge P, Dalgleish A G et al.. Tropical spastic paraparesis and human T cell lymphotropic virus type I in the United Kingdom.  Brain. 1989;  112 1057-1090
  PubMedGoogle Scholar
• 58 Leite A CC, Silva M TT, Alamy A H et al.. Peripheral neuropathy in HTLV-1 infected individuals without tropical spastic paraparesis/HTLV-1-associated myelopathy.  J Neurol. 2004;  251 877-881
  PubMedGoogle Scholar
• 59 Nascimento O JM, Araújo A Q, Freitas M RG, Escada T M, Andrad-Serpa M J. Peripheral nerve involvement in HTLV-I associated myelopathy [abstract].  J Acquir Immune Defic Syndr. 1995;  10 230
  PubMedGoogle Scholar
• 60 Ludolph A C, Hugon J, Román G C, Spencer P S, Schoenberg B S. A clinical neurophysiologic study of tropic spastic paraparesis.  Muscle Nerve. 1988;  11 392-397
  PubMedGoogle Scholar
• 61 Barkhaus P E, Morgan O. Jamaican neuropathy: an electrophysiological study.  Muscle Nerve. 1988;  11 380-385
  PubMedGoogle Scholar
• 62 Bhigjee A I, Bill P LA, Wiley C A et al.. Peripheral nerve lesions in HTLV-I associated myelopathy (HAM/TSP).  Muscle Nerve. 1993;  16 21-26
  PubMedGoogle Scholar
• 63 Douen A G, Pringle C E, Guberman A. Human T-cell lymphotropic virus type-1 myositis, peripheral neuropathy, and cerebral white matter lesions in the absence of spastic paraparesis.  Arch Neurol. 1997;  54 896-900
  PubMedGoogle Scholar
• 64 Said G, Goulon-Goeau C, Lacroix C, Fève A, Descamps H, Fouchard M. Inflammatory lesions of peripheral nerve in a patient with human T-lymphotropic virus type I-associated myelopathy.  Ann Neurol. 1988;  24 275-277
  CrossrefPubMedGoogle Scholar
• 65 Nakazato O, Mori T, Okajima T. Sural nerve pathology in HTLV-I-associated myelopathy. In: Roman G, Vernant JC, Osame M HTLV-1 and the Nervous System. New York; Alan R. Liss, Inc. 1989: 269-274
  Google Scholar
• 66 Nakazato O, Mori T, Okajima T. Sural nerve pathology in HTLV-I associated myelopathy.  Neurol Neurobiol. 1989;  51 269-274
  PubMedGoogle Scholar
• 67 Littleton E T, Man W D, Holton J L et al.. Human T cell leukemia virus type 1 associated neuromuscular disease causing respiratory failure.  J Neurol Neurosurg Psychiatry. 2002;  72 650-652
  CrossrefPubMedGoogle Scholar
• 68 Cupler E J, Leon-Monzon M, Miller J et al.. Inclusion body myositis in HIV and HTLV-1 infected patients.  Brain. 1996;  119 1887-1893
  PubMedGoogle Scholar
• 69 Ozden S, Gessain A, Gout O et al.. Sporadic inclusion body myositis in a patient with human T-cell leukemia virus type-1 associated myelopathy.  Clin Infect Dis. 2001;  32 510-514
  CrossrefPubMedGoogle Scholar
• 70 Leon-Monzon M, Illa I, Dalakas M C. Polymyositis in patients infected with human T-cell leukemia virus type 1: the role of the virus in the cause of the disease.  Ann Neurol. 1994;  36 643-649
  CrossrefPubMedGoogle Scholar
• 71 Morgan O S, Rodgers-Johnson P, Mora C, Char G. HTLV-1 and polymyositis in Jamaica.  Lancet. 1989;  2 1184-1187
  PubMedGoogle Scholar
• 72 Higuchi I, Nerenberg M, Yoshimine K et al.. Failure to detect HTLV-1 by in situ hybridization in the biopsied muscles of viral carriers with polymyositis.  Muscle Nerve. 1992;  15 43-44
  PubMedGoogle Scholar
• 73 Nishikai M, Sato A. Human T lymphocyte virus type I and polymyositis and dermatomyositis in Japan [letter].  Arthritis Rheum. 1991;  34 791-792
  PubMedGoogle Scholar
• 74 Inose M, Higuchi I, Yoshimine K et al.. Pathological changes in skeletal muscle in HTLV-1 seropositive myelopathy.  J Neurol Sci. 1992;  110 73-78
  CrossrefPubMedGoogle Scholar
• 75 Smadja D, Bellance R, Cabre P h et al.. Clinical characteristics of HTLV-1 associated dermato-polymyositis: seven cases from Martinique.  Acta Neurol Scand. 1995;  92 206-212
  PubMedGoogle Scholar
• 76 Sowa J M. Human T lymphotropic virus I, myelopathy, polymyositis, and synovitis: an expanding rheumatic spectrum.  J Rheumatol. 1992;  19 316-318
  PubMedGoogle Scholar
• 77 Gabbai A A, Wiley C A, Oliveira A SB et al.. Skeletal muscle involvement in tropical spastic paraparesis/HTLV-1-associated myelopathy.  Muscle Nerve. 1994;  17 923-930
  PubMedGoogle Scholar
• 78 Tarras S, Sheremata W A, Snodgrass S, Ayyar D R. Polymyositis and chronic myelopathy with presence of serum and cerebrospinal fluid antibody to HTLV-I. In: Roman G, Vernant JC, Osame M HTLV-1 and the Nervous System. New York; Alan R. Liss, Inc. 1989: 435-441
  Google Scholar

Gregory GruenerM.D. M.B.A. 

Department of Neurology, Loyola University Chicago, Stritch School of Medicine

2160 South First Avenue, Maywood, IL 60156